Cambogin suppresses dextran sulphate sodium‐induced colitis by enhancing Treg cell stability and function

Abstract

The effect of cambogin on DSS-induced colitis is expedited by a Treg-cell-mediated modification of the immune response, suggesting that cambogin could be applied as a novel agent for treating colitis and other Treg cell-related diseases.